<DOC>
	<DOCNO>NCT01939522</DOCNO>
	<brief_summary>Children/ young people diabetes may higher risk acquire certain infection . These infection include caused bacterium call pneumococcus cause pneumonia , meningitis ear infection . In UK old child diabetes give vaccine pneumococcus bug call Pneumovax ( PPS23 short ) . Although PPS23 cause good immune response child 2 year age actually know well PPS23 protect infection child age . In addition data adult child PPS23 may result reduce response future dose pneumococcal vaccine ( hyporesponsiveness ) . Because lack information well PPS23 protect potential hyporesponsiveness investigator would like study use alternative vaccine pneumococcus call Prevenar13 ( pCV13 ) . This vaccine know safe work well baby young child concern hyporesponsiveness . It approve use child 17 year age little information size duration immune response PCV13 child age 6 year old .</brief_summary>
	<brief_title>Protection Against Pneumococcal Infection Children With T1DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Diagnosis T1DM follow Oxfordshire Children 's Diabetes Service . Aged 6 year 17 year . Parent/legal guardian willing able give inform consent . No previous immunisation pneumococcal conjugate vaccine ( PCV ) . Willing allow General Practitioner notify participation study . Known allergic reaction vaccine antigen excipients . Bleeding diathesis condition associate prolonged bleeding time would contraindicate intramuscular injection .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>diabetes</keyword>
	<keyword>pneumococcal</keyword>
</DOC>